Omeprazole produces parietal cell hypertrophy and hyperplasia in humans

Digestive Diseases and Sciences

Volumn 41, Issue 10, 1996, Pages 2039-2047

  Driman, David K ^a,b   Wright, Cheryl ^a   Tougas, Gervais ^a   Riddell, Robert H ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Gastric body; Omeprazole; Parietal cells; Proton pump; Ranitidine

Indexed keywords

OMEPRAZOLE; RANITIDINE;

ARTICLE; CELL SIZE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ELECTRON MICROSCOPY; HUMAN; HUMAN TISSUE; HYPERPLASIA; HYPERTROPHY; MICROSCOPY; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH BIOPSY; STOMACH PARIETAL CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; CELL COUNT; CELL SIZE; HUMANS; HYPERPLASIA; HYPERTROPHY; MIDDLE AGED; OMEPRAZOLE; PARIETAL CELLS, GASTRIC; RANITIDINE;

EID: 0029861304     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02093608     Document Type: Article

References (38)

1. Massoomi F, Savage J, Destache CJ: Omeprazole: A comprehensive review. Pharmacotherapy 13:46-59, 1993
2. +-ATPase: The site of action of omeprazole. Scand J Gastroenterol Suppl 24:3-11, 1989
3. Arens MJ, Dent J: Acid pump blockers: What are their current therapeutic roles? Bailliere's Clin Gastroenterol 7:95-128, 1993
4. Solcia E, Rindi G, Silini E, Villani L: Enterochromaffin-like (ECL) cells and their growths: Relationships to gastrin, reduced acid secretion and gastritis. Bailliere's Clin Gastroenterol 7:149-65, 1993
5. Helander HF, Rutgersson K, Helander KG, Pisegna JP, Gardner JD, Maton PN: Stereologic investigations of human gastric mucosa. II. Oxyntic mucosa from patients with Zollinger-Ellison syndrome. Scand J Gastroenterol 27:875-883, 1992
6. 2-receptor antagonists. Virchows Arch A Pathol Anal Histopathol 417:305-309, 1990
7. 2-receptor antagonist - on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells. Hepatogastroenterology 30:205-210, 1983
8. +-ATPase inhibitor omeprazole. Aliment Pharmacol Ther 6:335-349, 1992
9. Blom H: Alterations in gastric mucosal morphology induced by long-term treatment with omeprazole in rats. Digestion 35:98-105, 1986
10. Safholm C, Havu N, Forssell H, Sundell G, Mattsson H: Effect of 7 years' daily oral administration of omeprazole to beagle dogs. Digestion 55:134-147, 1994
11. Helander HF, Sundell GW: Ultrastructure of inhibited parietal cells in the rat. Gastroenterology 87:1064-1071, 1984
12. Karasawa H, Tani N, Miwa T: The effect of omeprazole on ultrastructural changes in gastric parietal cells. Gastroenterol Jpn 23:1-8, 1988
13. Furuhashi M, Nakahara A, Fukutomi H, Kominami E, Uchiyama Y: Changes in subcellular structures of parietal cells in the rat gastric gland after omeprazole. Arch Histol Cytol 55:191-201, 1992
14. Inokuchi H, Kawai T, Hattori T, Kawai K: Omeprazole causes parietal cell damage, DNA synthesis and cellular proliferation in rat oxyntic mucosa. Eur J Gastroenterol Hepatol 4:207-214, 1992
15. Helander HF, Mattsson H, Elm G, Ottosson S: Structure and function of rat parietal cells during treatment with omeprazole, SCH 28080, SCH 32651, or ranitidine. Scand J Gastroenterol 25:799-809, 1990
16. Helander HF: Parietal cell structure during inhibition of acid secretion. Scand J Gastroenterol Suppl 101:21-26, 1984
17. Karam SM, Forte JG: Inhibiting gastric H(+)-K(+)-ATPase activity by omeprazole promotes degeneration and production of parietal cells. Am J Physiol 266:G745-G758, 1994
18. Kato S, Fujii T, Nakano K, Naganuma H, Nakagawa H: The effects of omeprazole on the ultrastructure of gastric parietal cells. J Pediatr Gastroenterol Nutr 19:91-96, 1994
19. +-ATPase blockade. Am J Physiol 254:G399-G407, 1988
20. Stolte M, Bethke B, Ruhl G, Ritter M: Omeprazole-induced pseudohypertrophy of gastric parietal cells. Z Gastroenterol 30:134-138, 1992
21. Ang ST, Lieberman DA, Ippoliti AF, Weber L, Weinstein WM: Long term omeprazole therapy in patients with Barrett's esophagus is associated with parietal cell hyperplasia. Gastroenterology 106:A1016, 1994 (abstract)
22. Weinstein WM, Ang ST, Ippoliti AF, Lieberman DA: Fundic gland polyps in patients on long term omeprazole therapy: A light and electron microscopic study of the gastric mucosa. Gastroenterology 106:A210, 1994 (abstract)
23. Hassall E, Dimmick J, Israel D: Parietal cell hyperplasia in children receiving omeprazole. Gastroenterology 108:A110, 1995
24. Lee SW, Lieberman DA, Ippoliti AF, Hsieh CY, Weinstein WM: Changes in the parietal cell mass after long term therapy with high dose omeprazole in Barrett's esophagus (BE): A two year prospective study. Gastroenterology 110:A173, 1996 (abstract)
25. Scott DR, Besancon M, Sachs G, Helander H: Effects of antisecretory agents on parietal cell structure and H/K-ATPase levels in rabbit gastric mucosa in vivo. Dig Dis Sci 39:2118-2126, 1994
26. Graham JR: Gastric polyposis: onset during long-term therapy with omeprazole. Med J Aust 157:287-288, 1992
27. Hirt M, Lee SW, Weinstein WM: Fundic gland polyps: A comparison of the omeprazole-associated and the sporadic types. Gastroenterology 110:A135, 1996 (abstract)
28. Lee RMKW: A critical appraisal of the effects of fixation, dehydration and embedding or cell volume. In The Science of Biological Specimen Preparation for Microscopy and Microanalysis. Revel J, Barnard T, Haggis GH (eds). O'Hare, Illinois, Scanning Electron Microscopy, Inc., 1984, pp 61-70
29. Helander HF, Hirschowitz BI: Quantitative ultrastructural studies on gastric parietal cells. Gastroenterology 63:951-961, 1972
30. Ito S, Schofield GC: Studies on the depletion and accumulation of microvilli and changes in the tubulovesicular compartment of mouse parietal cells in relation to gastric acid secretion. J Cell Biol 63:364-382, 1974
31. Forte TM, Machen TE, Forte JG: Ultrastructural changes in oxyntic cells associated with secretory function: A membrane-recycling hypothesis. Gastroenterology 73:941-955, 1977
32. Carlsson E, Larsson H, Mattsson H, Ryberg B, Sundell G: Pharmacology and toxicology of omeprazole - with special reference to the effects on the gastric mucosa. Scand J Gastroenterol Suppl 21:31-38, 1986
33. Lind T, Cederherg C, Ekenved G, Haglund U, Olbe L. Effect of omeprazole - a gastric proton pump inhibitor - on pentagastrin stimulated acid secretion in man. Gut 24:270-276, 1983
34. Sharma B, Axelson M, Pounder RP, Lundborg P, Ohman M, Santana A, Talbot M, Cederberg C: Acid secretory capacity and plasma gastrin concentration after administration of omeprazole to normal subjects. Aliment Pharmacol Ther 1:67-76, 1987
35. Sharma BK, Walt RP, Pounder RE, Gomes Md, Wood EC, Logan LH: Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 25:957-964, 1984
36. Lamberts R, Creutzfeldt W, Struber HG, Brunner G, Solcia E: Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis. Gastroenterology 104:1356-1370, 1993
37. Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH: Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 36:12-16, 1995
38. Stolte M, Baumann K, Bethke B, Ritter M, Lauer E, Eidt H: Active autoimmune gastritis without total atrophy of the glands. Z Gastroenterol 30:729-735, 1992